Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-21

Clinical Trial Update: An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating golimumab in active rheumatoid arthritis patients on methotrexate showed efficacy and safety results. The results were posted in March …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Golimumab (golimumab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2014-03-21